Eli Lilly (LLY) earnings Q4 2023

Eli Lilly (LLY) earnings Q4 2023

Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020.  Mike Blake | Reuters Eli Lilly on Tuesday reported fourth-quarter revenue and adjusted earnings that topped expectations on the strong launch of its new weight loss drug, Zepbound, and higher prices for its blockbuster diabetes drug, Mounjaro. … Read more

Novo Nordisk parent to buy Catalent to expand Wegovy supply

Novo Nordisk parent to buy Catalent to expand Wegovy supply

Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023.  Victoria Klesty | Reuters Novo Nordisk‘s parent company on Monday said it will acquire drug manufacturer Catalent in a $16.5 billion deal that could help boost the supply of the highly popular weight loss injection … Read more

Norway wealth fund says Novo, Eli Lilly may join trillion-dollar club

Norway wealth fund says Novo, Eli Lilly may join trillion-dollar club

A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023.  George Frey | Reuters Norway’s giant wealth fund, the world’s largest, touted the possibility that Danish drugmaker Novo Nordisk and U.S. rival Eli Lilly … Read more

Everything from health care to industrials

Everything from health care to industrials

During the January Monthly Meeting this past Wednesday, we took questions directly from Investing Club members. Here are Jim Cramer’s and Director of Portfolio Analysis Jeff Marks’ responses. Their answers have been edited for clarity. 1. What is a good entry point for Eaton ? It doesn’t seem to want to go down! (Brian) Jim … Read more

Merck, J&J CEOs agree to testify in Senate hearing on drug prices

Merck, J&J CEOs agree to testify in Senate hearing on drug prices

US Senator Bernie Sanders, Independent of Vermont, speaks during a rally by the People’s Action, protesting pharmaceutical companies’ lobbying against allowing Medicare to negotiate lower prescription drug prices, outside Pharmaceutical Research and Manufacturers of America (PhRMA) headquarters in Washington, DC, September 21, 2021. Saul Loeb | AFP | Getty Images The CEOs of Merck and … Read more

Treasury yields fractionally higher ahead of key data releases

Treasury yields fractionally higher ahead of key data releases

U.S. Treasury yields nudged slightly higher on Tuesday morning, as market participants await the release of key economic data points later in the week. Near 2:25 a.m. ET, the yield on the benchmark 10-year Treasury note was around 1.7 basis points higher at 4.1109% while the yield on the 30-year Treasury bond was up just … Read more

Cramer says Eli Lilly could join the ranks of the ‘Magnificent Seven’

Cramer says Eli Lilly could join the ranks of the ‘Magnificent Seven’

CNBC’s Jim Cramer on Monday suggested Tesla could lose its spot in the “Magnificent Seven” megacap stocks list. He said he’s waiting to see results from the electric vehicle giant’s upcoming earnings report, but said Tesla may have hit a “growth pause,” compared to its Big Tech peers that are still on the rise. If … Read more

Jim Cramer’s top 10 things to watch in the stock market Monday

Jim Cramer’s top 10 things to watch in the stock market Monday

My top 10 things to watch Monday, Jan. 22 1. This is a big week for the markets. As I wrote in my Sunday column , we will find out what it is that will propel stocks forward — or in reverse — following the S & P 500’s new record high on Friday. A … Read more

The S&P 500 set a new record high. How our current Club stocks have fared since the last one

The S&P 500 set a new record high. How our current Club stocks have fared since the last one

The S & P 500 notched a record close Friday for the first time in more than two years — and over that time, no Club stock has performed better than Eli Lilly . The broad market index ended Friday’s session at 4,839.81, edging out its prior all-time high close of 4,796.56 set on Jan. … Read more

We like health-care stocks in 2024 despite presidential election year weakness

We like health-care stocks in 2024 despite presidential election year weakness

As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly , could defy historical convention. The S & P 500 Health Care Sector … Read more